Nelson Obus Net Worth

The estimated Net Worth of Nelson Obus is at least $25.6 Million dollars as of 11 January 2021. Mr. Obus owns over 20,000 units of Lifecore Biomedical Inc stock worth over $25,450,428 and over the last 16 years he sold LNDC stock worth over $0. In addition, he makes $154,042 as Independent Director at Lifecore Biomedical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Obus LNDC stock SEC Form 4 insiders trading

Nelson has made over 22 trades of the Lifecore Biomedical Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of LNDC stock worth $215,200 on 11 January 2021.

The largest trade he's ever made was buying 289,191 units of Lifecore Biomedical Inc stock on 4 January 2016 worth over $1,518,253. On average, Nelson trades about 17,180 units every 98 days since 2009. As of 11 January 2021 he still owns at least 2,905,300 units of Lifecore Biomedical Inc stock.

You can see the complete history of Mr. Obus stock trades at the bottom of the page.

Nelson Obus biography

Nelson Obus serves as Independent Director of the Company. Mr. Obus has served as a member of the Board of Directors since October 2018. Mr. Obus is Managing Member of Wynnefield Capital Management, LLC and a General Partner at Wynnefield Capital, Inc. and his prior associations include positions with Schaffer Capital Management and Lazard Freres. Mr. Obus presently serves on the board of directors of Global Power Equipment Group Inc. and MK Acquisition LLC and previously served on the board of directors of Layne Christensen Company, Breeze-Eastern Corporation and Underground Solutions Inc.

What is the salary of Nelson Obus?

As the Independent Director of Lifecore Biomedical Inc, the total compensation of Nelson Obus at Lifecore Biomedical Inc is $154,042. There are 13 executives at Lifecore Biomedical Inc getting paid more, with Dr. Albert D. Bolles Ph.D. having the highest compensation of $989,459.

How old is Nelson Obus?

Nelson Obus is 73, he's been the Independent Director of Lifecore Biomedical Inc since . There are 1 older and 19 younger executives at Lifecore Biomedical Inc. The oldest executive at Lifecore Biomedical Inc is Charles Macaluso, 76, who is the Independent Director.

What's Nelson Obus's mailing address?

Nelson's mailing address filed with the SEC is C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA, CA, 93455.

Insiders trading at Lifecore Biomedical Inc

Over the last 21 years, insiders at Lifecore Biomedical Inc have traded over $49,493,033 worth of Lifecore Biomedical Inc stock and bought 1,245,307 units worth $12,385,872 . The most active insiders traders include Nicholas Tompkins, Partners Small Cap Value Lp..., and Gary T Steele. On average, Lifecore Biomedical Inc executives and independent directors trade stock every 17 days with the average trade being worth of $253,944. The most recent stock trade was executed by Partners Small Cap Value Lp... on 24 October 2022, trading 250,000 units of LNDC stock currently worth $2,022,500.

What does Lifecore Biomedical Inc do?

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.

Complete history of Mr. Obus stock trades at Jason Industries, Lifecore Biomedical Inc, MVC Capital Inc, and MVC Capital Inc

Lifecore Biomedical Inc executives and stock owners

Lifecore Biomedical Inc executives and other stock owners filed with the SEC include:

• Dr. Albert D. Bolles Ph.D.,
  CEO, Pres & Director
• Albert Bolles,
  President, Chief Executive Officer, Director
• James Hall,
  Vice President, President of Lifecore
• James G. Hall,
  VP & Pres of Lifecore
• Timothy Burgess,
  Senior Vice President of Supply Chain for Curation Foods
• Brian McLaughlin,
  Chief Financial Officer, Secretary
• John D. Morberg,
  CFO & Sec.
• Timothy P. Burgess,
  Sr. VP of Supply Chain - Curation Foods
• Dawn Kimball,
  Chief Human Resource Officer, Senior Vice President
• Andrew Powell,
  Independent Director
• Tonia Pankopf,
  Independent Director
• Deborah Carosella,
  Independent Director
• Catherine Sohn,
  Independent Director
• Nelson Obus,
  Independent Director
• Katrina Houde,
  Independent Director
• Craig Barbarosh,
  Independent Chairman of the Board
• Charles Macaluso,
  Independent Director
• Patrick Walsh,
  Director
• Joshua Schechter,
  Director
• Jeffrey Edwards,
  Director
• Parker K. Javid,
  VP
• Aaron Perlitsh,
  Director of Internal Audit & Chief Compliance Officer
• Steven D Goldby,
  Director
• Ronald Lane Midyett,
  Executive Vice President
• Nicholas Tompkins,
  CEO & President, Apio Inc.
• Robert Tobin,
  Director
• Steven P Bitler,
  Vice President, Technology
• Larry D Hiebert,
  Executive Vice President
• Molly Hemmeter,
  VP Business Development
• Gary T Steele,
  President & CEO
• Gregory S Skinner,
  Chief Financial Officer
• John D Morberg,
  Chief Financial Officer
• Parker K Javid,
  Vice President
• Dennis J Allingham,
  Executive Vice President
• Richard Dulude,
  Director
• Kenneth E Jones,
  Director
• Richard Dean Hollis,
  Director
• Duke K Bristow,
  Director
• Kirby L Cramer,
  Director
• Stephen E Halprin,
  Director
• David D Taft,
  Director
• Lawrence Greene,
  V.P. Manufacturing
• Frederick Frank,
  Director
• Partners Small Cap Value Lp...,
  
• Damian A. Hajduk,
  Chief Scientific Officer
• Thomas F Crowley,
  CEO, LandecAg
• Richard S Schneider,
  Director
• Fred Frank,
  Director
• Raymond H Diradoorian,
  Director